These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11169413)

  • 1. Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph node.
    Becker JC; Vetter CS; Schrama D; Bröcker EB; thor Straten P
    Eur J Immunol; 2000 Dec; 30(12):3699-706. PubMed ID: 11169413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC
    J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of inhibitory or activating CD94/NKG2 subtypes on MART-1-reactive T cells in vitiligo versus melanoma: a case report.
    Pedersen LØ; Vetter CS; Mingari MC; Andersen MH; thor Straten P; Bröcker EB; Becker JC
    J Invest Dermatol; 2002 Apr; 118(4):595-9. PubMed ID: 11918704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes.
    Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G
    J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity.
    Noppen C; Schaefer C; Zajac P; Schütz A; Kocher T; Kloth J; Heberer M; Colonna M; De Libero G; Spagnoli GC
    Eur J Immunol; 1998 Apr; 28(4):1134-42. PubMed ID: 9565352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.
    Besostri B; Beggiato E; Bianchi A; Mariani S; Coscia M; Peola S; Foglietta M; Boccadoro M; Pileri A; Moretta L; Massaia M
    Br J Haematol; 2000 Apr; 109(1):46-53. PubMed ID: 10848781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals.
    André P; Brunet C; Guia S; Gallais H; Sampol J; Vivier E; Dignat-George F
    Eur J Immunol; 1999 Apr; 29(4):1076-85. PubMed ID: 10229073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones.
    Boullier S; Poquet Y; Halary F; Bonneville M; Fournie JJ; Gougeon ML
    Eur J Immunol; 1998 Nov; 28(11):3399-410. PubMed ID: 9842883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene.
    Cantoni C; Biassoni R; Pende D; Sivori S; Accame L; Pareti L; Semenzato G; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 1998 Jan; 28(1):327-38. PubMed ID: 9485212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
    Derre L; Corvaisier M; Pandolfino MC; Diez E; Jotereau F; Gervois N
    J Immunol; 2002 May; 168(10):4864-70. PubMed ID: 11994435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
    Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
    J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
    Wojtasiak M; Jones CM; Sullivan LC; Winterhalter AC; Carbone FR; Brooks AG
    Int Immunol; 2004 Sep; 16(9):1333-41. PubMed ID: 15302848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T; Heredia AB; Llano M; Minguela A; Rodriguez A; López-Botet M; Aparicio P
    J Immunol; 1999 Apr; 162(7):3996-4002. PubMed ID: 10201920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses.
    Ortega C; Romero P; Palma A; Orta T; Peña J; García-Vinuesa A; Molina IJ; Santamaría M
    Immunol Cell Biol; 2004 Dec; 82(6):587-95. PubMed ID: 15550116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD94/NKG2 in innate and adaptive immunity.
    Gunturi A; Berg RE; Forman J
    Immunol Res; 2004; 30(1):29-34. PubMed ID: 15258309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.